Determinants of treatment
decisions of patients with pancreatic cancer in shared decision-making:
A qualitative study
Leonieke Daanen1 2* , Mirelle
Hanskamp-Sebregts2, Inger Abma3,
Philip van der Wees3, Kees van
Laarhoven4, Anneke de Jong5, Marion
van der Kolk4
* Corresponding author:
Leonieke.Daanen@radboudumc.nl,
+ 31 24 36 17835
1 Radboud University Medical Center, Emergency
Department, internal postal code 760, PO Box 9101, 6500 HB Nijmegen, the
Netherlands
2 Radboud University Medical Center, Institute of
Quality Assurance and Patient Safety,
internal postal code 348, PO Box
9101, 6500 HB Nijmegen, the Netherlands
3 Radboud Institute of Health Sciences, IQ healthcare,
internal postal code 114, PO Box 9101, 6500 HB Nijmegen, the Netherlands
4 Radboud University Medical Center, Department of
Surgery, internal postal code 618, PO Box 9101, 6500 HB Nijmegen, the
Netherlands
5 University of Applied Sciences, Master of Care
Trajectory Design, Heidelberglaan 8,
3584 CS Utrecht, the Netherlands
Abstract Word Count: 298 words
Manuscript Word Count: 3.128 words (excluding title page, abstract,
references and tables)
Abstract
Rationale
and aims
Shared decision-making is an approach whereby clinicians and patients
make decisions together using the best available evidence. The most
common cancers studied in relation to shared decision-making are breast
and prostate. However, little is known about shared decision-making in
patients with pancreatic cancer. We aimed to identify the determinants
that influence pancreatic cancer patients in making treatment decisions
during shared decision-making.